Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on December 3, 2009
J Am Soc Nephrol 21: 337-344, 2010
© 2010 American Society of Nephrology
doi: 10.1681/ASN.2009070725

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
ASN.2009070725v1
21/2/337    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Köttgen, A.
Right arrow Articles by Fox, C. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Köttgen, A.
Right arrow Articles by Fox, C. S.
Related Collections
Right arrowRelated Articles

CLINICAL EPIDEMIOLOGY

Uromodulin Levels Associate with a Common UMOD Variant and Risk for Incident CKD

Anna Köttgen*, Shih-Jen Hwang{dagger},{ddagger}, Martin G. Larson§, Jennifer E. Van Eyk||, Qin Fu||, Emelia J. Benjamin{dagger}, Abbas Dehghan**, Nicole L. Glazer{dagger}{dagger}, W.H. Linda Kao*, Tamara B. Harris{ddagger}{ddagger}, Vilmundur Gudnason§§,||||, Michael G. Shlipak¶¶, Qiong Yang§, Josef Coresh*, Daniel Levy{dagger},{ddagger} and Caroline S. Fox{dagger},{ddagger},***

*Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;
{dagger}Framingham Heart Study, Framingham, Massachusetts;
{ddagger}Center for Population Studies, National Heart, Lung, and Blood Institute, and
{ddagger}{ddagger}Laboratory of Epidemiology, Demography, and Biometry, Intramural Research Program, National Institute on Aging, National Institutes of Health, Bethesda, Maryland;
Departments of §Biostatistics and
Epidemiology, Boston University School of Public Health, Boston, Massachusetts;
||Department of Medicine, Johns Hopkins University, Baltimore, Maryland;
**Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands;
{dagger}{dagger}Cardiovascular Health Research Unit and Department of Medicine, University of Washington, Seattle, Washington;
§§Icelandic Heart Association Research Institute, Kopavogur, Iceland;
||||University of Iceland, Reykjavik, Iceland;
¶¶General Internal Medicine Division, San Francisco VA Medical Center, University of California, San Francisco, California; and
***Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

Correspondence: Dr. Caroline S. Fox, 73 Mount Wayte Avenue, Suite #2, Framingham, MA 01702. Phone: 508-935-3447; Fax: 508-626-1262; E-mail: foxca{at}nhlbi.nih.gov

Received for publication July 15, 2009. Accepted for publication October 13, 2009.

Common variants in the region of the UMOD gene, which encodes uromodulin (Tamm-Horsfall protein), associate with chronic kidney disease (CKD) and estimated GFR (eGFR). Whether uromodulin levels associate with UMOD variants or with the risk for developing CKD is unknown. We conducted an age- and gender-matched case-control study (n = 200) of incident CKD (eGFR <60 ml/min per 1.73 m2) within the Framingham Heart Study (FHS). Baseline urinary uromodulin concentrations were related to case-control status 9.9 yr later and to genotype at rs4293393. As a replication set, we tested the genotype association with uromodulin concentration in the Atherosclerosis Risk in Communities (ARIC) Study (n = 42). Geometric means of uromodulin concentrations were 51% higher in case than in control subjects (P = 0.016). The adjusted odds ratio of CKD per 1-SD higher concentration of uromodulin was 1.72 (95% confidence interval 1.07 to 2.77; P = 0.03) after accounting for CKD risk factors and baseline eGFR. We observed lower urinary uromodulin concentrations per each copy of the C allele at rs4293393 in both cohorts. In summary, elevated uromodulin concentrations precede the onset of CKD and associate with a common polymorphism in the UMOD region.


Related Articles

Uromodulin and Translational Medicine: Will the SNPs Bring Zip to Clinical Practice?
John R. Sedor
J. Am. Soc. Nephrol. 2010 21: 204-206. [Full Text] [PDF]

This Month's Highlights
J. Am. Soc. Nephrol. 2010 21: A16. [Full Text] [PDF]

Uromodulin and Translational Medicine: Will the SNPs Bring Zip to Clinical Practice?
John R. Sedor
J. Am. Soc. Nephrol. 2010 21: 204-206. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
Uromodulin and Translational Medicine: Will the SNPs Bring Zip to Clinical Practice?
J. Am. Soc. Nephrol., February 1, 2010; 21(2): 204 - 206.





HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP